Uncategorised - European Medical Journal

Can the UK reclaim its status as a life sciences leader?

Two UK health leaders reveal how to boost life sciences R&D, attract investment and make the UK a global hub for innovation once more.

atopic dermatitis

Psychiatric Comorbidities in Atopic Dermatitis

This finding highlights that even small differences may have meaningful public health implications, given the high global prevalence of AD.

Changes in Oral Microbiome Linked to Relapsing-Remitting Multiple Sclerosis

New study shows oral microbiome imbalance and reduced salivary hypotaurine may contribute to neuroinflammation in relapsing-remitting MS.

Curcumin in MASLD and Type 2 Diabetes Treatment

A 12-month randomised controlled trial investigated curcumin supplementation in Type 2 diabetes treatment, specifically its effects on liver steatosis.

Cholesterol and Dementia Links in Genetic Meta-Analysis

New genetic research explores whether lowering cholesterol can protect against dementia across major populations.

Cell-based flu vaccines could offer 20% more protection

CSL Seqirus real-world study finds cell-based flu vaccines offer stronger protection than egg-based options in 2023/24 season.

Healthcare professional preparing HIV preventive treatment injection; close-up of lenacapavir vial and syringe; concept of affordable HIV prevention and global treatment access

IDWeek 2025: HIV Prevention Breakthrough Could Cost $25 Annually

A new study presented at IDWeek 2025 suggests that HIV preventive treatment with lenacapavir could be produced for as little as $25 per patient per year.

Nebulized therapy concept for COPD symptom relief with ensifentrine

CHEST 2025: Ensifentrine Boosts Quality of Life in COPD

Ensifentrine improved symptoms, dyspnea, and quality of life in stable COPD without exacerbations in ENHANCE trials.

sickle cell disease

Gene-Editing Therapy Boosts Quality of Life in Sickle Cell Disease

Gene-editing therapy exa-cel dramatically improved pain and quality of life in sickle cell disease.

Cardiopulmonary exercise test assessing cardiorespiratory fitness in psoriatic arthritis

Psoriatic Arthritis Shows Lower Cardiorespiratory Fitness Levels

Cross-sectional testing shows reduced cardiorespiratory fitness in psoriatic arthritis, with disease activity and adiposity linked to lower VO2peak and self-reported activity linked to higher fitness.